New Year, New Mission: Oxford Treatment Center Empowers Veterans to Reclaim Their Lives in 2026
ETTA, Miss., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Veterans face substance use disorders at disproportionately high rates. More than one...
Veterans
Cheelcare Announces Second Quarter Fiscal 2026 Financial Results
Markham, Ontario--(Newsfile Corp. - December 30, 2025) - Cheelcare Inc. (TSXV: CHER) ("Cheelcare" or the "Company"), a Canadian innovator in...
President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else
"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within the timelines required by law,...
Relapse Risk Increases During the Holidays; Desert Hope Treatment Center Urges Early Support
LAS VEGAS, Dec. 24, 2025 (GLOBE NEWSWIRE) -- This holiday season, addiction experts at Desert Hope Treatment Center are encouraging individuals...
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a...
LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for Its State-of-the-Art Test Demonstration Facility Located at the K-1330 Building on the Historic K-25 Site
LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Reached Critical Regulatory Milestone with Receipt of...
LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for Its State-of-the-Art Test Demonstration Facility Located at the K-1330 Building on the Historic K-25 Site
LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Reached Critical Regulatory Milestone with Receipt of...
Avicanna Announces Changes to its Board of Directors
TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical...
World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
TORONTO, ONTARIO / ACCESS Newswire / December 22, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands that Quantum BioPharma shareholder...
SIERRA7 RECOGNIZED AS A 2026 ELEV8 GOVCON AWARD WINNER
MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions, is proud to announce that...
Avicanna Applauds President Trump’s Executive Order to Reclassify Cannabis & Provides Scientific Update
Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna’s 2025 advances across R&D, clinical development, and medical...
Alleva Introduces InCheck: Transforming Behavioral Health Compliance Into a Year-Round System
LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced InCheck, a comprehensive compliance management...
Alleva Introduces InCheck: Transforming Behavioral Health Compliance Into a Year-Round System
LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced InCheck, a comprehensive compliance management...
Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer
Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public...
Matt Kazan, former Senate Finance advisor, returns to Avalere Health as Senior Vice President, Policy, and Laura Housman elevates to Chief Public Health Officer
Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public...
ID.me Announces Contract with CMS to Advance Access, Security, and User Experience on Medicare.gov
MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare...
ID.me Announces Contract with CMS to Advance Access, Security, and User Experience on Medicare.gov
MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare...
The Great American Elderverse™ Comes to Texas
Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower...
The Great American Elderverse™ Comes to Texas
Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower...
Recludix Pharma Announces FDA Clearance of Investigational New Drug Application for REX-8756, an Oral STAT6 Inhibitor, to Enter into the Clinic
REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in...